眼がん治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Eye Cancer Treatment Market Insights, Forecast to 2028

• レポートコード：QY2207C3457 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の眼がん治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に眼がん治療の世界市場のxxx％を占める「経口」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の眼がん治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの眼がん治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの眼がん治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 眼がん治療のグローバル主要メーカーには、Novartis AG、Spectrum Pharmaceuticals,Inc、GlaxoSmithKline plc、Bayer AG、Amgen ,Inc、Takeda Pharmaceuticals Company Limited、Eli Lilly and Company、AstraZeneca、F.Hoffmann-La Roche Ltd、Janssen Global Services ,LLC、Sanofi、Abbvie ,Inc、Pfizer ,Inc、Merck & Co,Incなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 眼がん治療市場は、種類と用途によって区分されます。世界の眼がん治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 経口、静脈内、熱帯、その他 【用途別セグメント】 病院、診療所、がんセンター、診断センター、外来外科センター、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 眼がん治療製品概要 - 種類別市場（経口、静脈内、熱帯、その他） - 用途別市場（病院、診療所、がんセンター、診断センター、外来外科センター、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の眼がん治療販売量予測2017-2028 - 世界の眼がん治療売上予測2017-2028 - 眼がん治療の地域別販売量 - 眼がん治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別眼がん治療販売量 - 主要メーカー別眼がん治療売上 - 主要メーカー別眼がん治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（経口、静脈内、熱帯、その他） - 眼がん治療の種類別販売量 - 眼がん治療の種類別売上 - 眼がん治療の種類別価格 ・用途別市場規模（病院、診療所、がんセンター、診断センター、外来外科センター、その他） - 眼がん治療の用途別販売量 - 眼がん治療の用途別売上 - 眼がん治療の用途別価格 ・北米市場 - 北米の眼がん治療市場規模（種類別、用途別） - 主要国別の眼がん治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの眼がん治療市場規模（種類別、用途別） - 主要国別の眼がん治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の眼がん治療市場規模（種類別、用途別） - 主要国別の眼がん治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の眼がん治療市場規模（種類別、用途別） - 主要国別の眼がん治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの眼がん治療市場規模（種類別、用途別） - 主要国別の眼がん治療市場規模（トルコ、サウジアラビア） ・企業情報 Novartis AG、Spectrum Pharmaceuticals,Inc、GlaxoSmithKline plc、Bayer AG、Amgen ,Inc、Takeda Pharmaceuticals Company Limited、Eli Lilly and Company、AstraZeneca、F.Hoffmann-La Roche Ltd、Janssen Global Services ,LLC、Sanofi、Abbvie ,Inc、Pfizer ,Inc、Merck & Co,Inc ・産業チェーン及び販売チャネル分析 - 眼がん治療の産業チェーン分析 - 眼がん治療の原材料 - 眼がん治療の生産プロセス - 眼がん治療の販売及びマーケティング - 眼がん治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 眼がん治療の産業動向 - 眼がん治療のマーケットドライバー - 眼がん治療の課題 - 眼がん治療の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Eye Cancer Treatment Market
The global Eye Cancer Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Oral accounting for % of the Eye Cancer Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Eye Cancer Treatment market size is valued at US$ million in 2021, while the North America and Europe Eye Cancer Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Eye Cancer Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Eye Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Eye Cancer Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Eye Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Eye Cancer Treatment market.
Global Eye Cancer Treatment Scope and Market Size
Eye Cancer Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Eye Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral
Intravenous
Tropical
Others
Segment by Application
Hospital
Clinics
Cancer Centers
Diagnostic Centers
Ambulatory Surgical Centers
Others
By Company
Novartis AG
Spectrum Pharmaceuticals,Inc
GlaxoSmithKline plc
Bayer AG
Amgen ,Inc
Takeda Pharmaceuticals Company Limited
Eli Lilly and Company
AstraZeneca
F.Hoffmann-La Roche Ltd
Janssen Global Services ,LLC
Sanofi
Abbvie ,Inc
Pfizer ,Inc
Merck & Co,Inc
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eye Cancer Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Intravenous
1.2.4 Tropical
1.2.5 Others
1.3 Market by Application
1.3.1 Global Eye Cancer Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Cancer Centers
1.3.5 Diagnostic Centers
1.3.6 Ambulatory Surgical Centers
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Eye Cancer Treatment Market Perspective (2017-2028)
2.2 Eye Cancer Treatment Growth Trends by Region
2.2.1 Eye Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Eye Cancer Treatment Historic Market Size by Region (2017-2022)
2.2.3 Eye Cancer Treatment Forecasted Market Size by Region (2023-2028)
2.3 Eye Cancer Treatment Market Dynamics
2.3.1 Eye Cancer Treatment Industry Trends
2.3.2 Eye Cancer Treatment Market Drivers
2.3.3 Eye Cancer Treatment Market Challenges
2.3.4 Eye Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Eye Cancer Treatment Players by Revenue
3.1.1 Global Top Eye Cancer Treatment Players by Revenue (2017-2022)
3.1.2 Global Eye Cancer Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Eye Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Eye Cancer Treatment Revenue
3.4 Global Eye Cancer Treatment Market Concentration Ratio
3.4.1 Global Eye Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eye Cancer Treatment Revenue in 2021
3.5 Eye Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Eye Cancer Treatment Product Solution and Service
3.7 Date of Enter into Eye Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Eye Cancer Treatment Breakdown Data by Type
4.1 Global Eye Cancer Treatment Historic Market Size by Type (2017-2022)
4.2 Global Eye Cancer Treatment Forecasted Market Size by Type (2023-2028)
5 Eye Cancer Treatment Breakdown Data by Application
5.1 Global Eye Cancer Treatment Historic Market Size by Application (2017-2022)
5.2 Global Eye Cancer Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Eye Cancer Treatment Market Size (2017-2028)
6.2 North America Eye Cancer Treatment Market Size by Type
6.2.1 North America Eye Cancer Treatment Market Size by Type (2017-2022)
6.2.2 North America Eye Cancer Treatment Market Size by Type (2023-2028)
6.2.3 North America Eye Cancer Treatment Market Share by Type (2017-2028)
6.3 North America Eye Cancer Treatment Market Size by Application
6.3.1 North America Eye Cancer Treatment Market Size by Application (2017-2022)
6.3.2 North America Eye Cancer Treatment Market Size by Application (2023-2028)
6.3.3 North America Eye Cancer Treatment Market Share by Application (2017-2028)
6.4 North America Eye Cancer Treatment Market Size by Country
6.4.1 North America Eye Cancer Treatment Market Size by Country (2017-2022)
6.4.2 North America Eye Cancer Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Eye Cancer Treatment Market Size (2017-2028)
7.2 Europe Eye Cancer Treatment Market Size by Type
7.2.1 Europe Eye Cancer Treatment Market Size by Type (2017-2022)
7.2.2 Europe Eye Cancer Treatment Market Size by Type (2023-2028)
7.2.3 Europe Eye Cancer Treatment Market Share by Type (2017-2028)
7.3 Europe Eye Cancer Treatment Market Size by Application
7.3.1 Europe Eye Cancer Treatment Market Size by Application (2017-2022)
7.3.2 Europe Eye Cancer Treatment Market Size by Application (2023-2028)
7.3.3 Europe Eye Cancer Treatment Market Share by Application (2017-2028)
7.4 Europe Eye Cancer Treatment Market Size by Country
7.4.1 Europe Eye Cancer Treatment Market Size by Country (2017-2022)
7.4.2 Europe Eye Cancer Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Eye Cancer Treatment Market Size (2017-2028)
8.2 Asia-Pacific Eye Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Eye Cancer Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Eye Cancer Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Eye Cancer Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Eye Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Eye Cancer Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Eye Cancer Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Eye Cancer Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Eye Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Eye Cancer Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Eye Cancer Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Eye Cancer Treatment Market Size (2017-2028)
9.2 Latin America Eye Cancer Treatment Market Size by Type
9.2.1 Latin America Eye Cancer Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Eye Cancer Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Eye Cancer Treatment Market Share by Type (2017-2028)
9.3 Latin America Eye Cancer Treatment Market Size by Application
9.3.1 Latin America Eye Cancer Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Eye Cancer Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Eye Cancer Treatment Market Share by Application (2017-2028)
9.4 Latin America Eye Cancer Treatment Market Size by Country
9.4.1 Latin America Eye Cancer Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Eye Cancer Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Eye Cancer Treatment Market Size (2017-2028)
10.2 Middle East & Africa Eye Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Eye Cancer Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Eye Cancer Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Eye Cancer Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Eye Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Eye Cancer Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Eye Cancer Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Eye Cancer Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Eye Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Eye Cancer Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Eye Cancer Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Eye Cancer Treatment Introduction
11.1.4 Novartis AG Revenue in Eye Cancer Treatment Business (2017-2022)
11.1.5 Novartis AG Recent Developments
11.2 Spectrum Pharmaceuticals,Inc
11.2.1 Spectrum Pharmaceuticals,Inc Company Details
11.2.2 Spectrum Pharmaceuticals,Inc Business Overview
11.2.3 Spectrum Pharmaceuticals,Inc Eye Cancer Treatment Introduction
11.2.4 Spectrum Pharmaceuticals,Inc Revenue in Eye Cancer Treatment Business (2017-2022)
11.2.5 Spectrum Pharmaceuticals,Inc Recent Developments
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Details
11.3.2 GlaxoSmithKline plc Business Overview
11.3.3 GlaxoSmithKline plc Eye Cancer Treatment Introduction
11.3.4 GlaxoSmithKline plc Revenue in Eye Cancer Treatment Business (2017-2022)
11.3.5 GlaxoSmithKline plc Recent Developments
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Eye Cancer Treatment Introduction
11.4.4 Bayer AG Revenue in Eye Cancer Treatment Business (2017-2022)
11.4.5 Bayer AG Recent Developments
11.5 Amgen ,Inc
11.5.1 Amgen ,Inc Company Details
11.5.2 Amgen ,Inc Business Overview
11.5.3 Amgen ,Inc Eye Cancer Treatment Introduction
11.5.4 Amgen ,Inc Revenue in Eye Cancer Treatment Business (2017-2022)
11.5.5 Amgen ,Inc Recent Developments
11.6 Takeda Pharmaceuticals Company Limited
11.6.1 Takeda Pharmaceuticals Company Limited Company Details
11.6.2 Takeda Pharmaceuticals Company Limited Business Overview
11.6.3 Takeda Pharmaceuticals Company Limited Eye Cancer Treatment Introduction
11.6.4 Takeda Pharmaceuticals Company Limited Revenue in Eye Cancer Treatment Business (2017-2022)
11.6.5 Takeda Pharmaceuticals Company Limited Recent Developments
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Eye Cancer Treatment Introduction
11.7.4 Eli Lilly and Company Revenue in Eye Cancer Treatment Business (2017-2022)
11.7.5 Eli Lilly and Company Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Eye Cancer Treatment Introduction
11.8.4 AstraZeneca Revenue in Eye Cancer Treatment Business (2017-2022)
11.8.5 AstraZeneca Recent Developments
11.9 F.Hoffmann-La Roche Ltd
11.9.1 F.Hoffmann-La Roche Ltd Company Details
11.9.2 F.Hoffmann-La Roche Ltd Business Overview
11.9.3 F.Hoffmann-La Roche Ltd Eye Cancer Treatment Introduction
11.9.4 F.Hoffmann-La Roche Ltd Revenue in Eye Cancer Treatment Business (2017-2022)
11.9.5 F.Hoffmann-La Roche Ltd Recent Developments
11.10 Janssen Global Services ,LLC
11.10.1 Janssen Global Services ,LLC Company Details
11.10.2 Janssen Global Services ,LLC Business Overview
11.10.3 Janssen Global Services ,LLC Eye Cancer Treatment Introduction
11.10.4 Janssen Global Services ,LLC Revenue in Eye Cancer Treatment Business (2017-2022)
11.10.5 Janssen Global Services ,LLC Recent Developments
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Eye Cancer Treatment Introduction
11.11.4 Sanofi Revenue in Eye Cancer Treatment Business (2017-2022)
11.11.5 Sanofi Recent Developments
11.12 Abbvie ,Inc
11.12.1 Abbvie ,Inc Company Details
11.12.2 Abbvie ,Inc Business Overview
11.12.3 Abbvie ,Inc Eye Cancer Treatment Introduction
11.12.4 Abbvie ,Inc Revenue in Eye Cancer Treatment Business (2017-2022)
11.12.5 Abbvie ,Inc Recent Developments
11.13 Pfizer ,Inc
11.13.1 Pfizer ,Inc Company Details
11.13.2 Pfizer ,Inc Business Overview
11.13.3 Pfizer ,Inc Eye Cancer Treatment Introduction
11.13.4 Pfizer ,Inc Revenue in Eye Cancer Treatment Business (2017-2022)
11.13.5 Pfizer ,Inc Recent Developments
11.14 Merck & Co,Inc
11.14.1 Merck & Co,Inc Company Details
11.14.2 Merck & Co,Inc Business Overview
11.14.3 Merck & Co,Inc Eye Cancer Treatment Introduction
11.14.4 Merck & Co,Inc Revenue in Eye Cancer Treatment Business (2017-2022)
11.14.5 Merck & Co,Inc Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Eye Cancer Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of Intravenous
Table 4. Key Players of Tropical
Table 5. Key Players of Others
Table 6. Global Eye Cancer Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Eye Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Eye Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Eye Cancer Treatment Market Share by Region (2017-2022)
Table 10. Global Eye Cancer Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Eye Cancer Treatment Market Share by Region (2023-2028)
Table 12. Eye Cancer Treatment Market Trends
Table 13. Eye Cancer Treatment Market Drivers
Table 14. Eye Cancer Treatment Market Challenges
Table 15. Eye Cancer Treatment Market Restraints
Table 16. Global Eye Cancer Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Eye Cancer Treatment Revenue Share by Players (2017-2022)
Table 18. Global Top Eye Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Cancer Treatment as of 2021)
Table 19. Ranking of Global Top Eye Cancer Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Eye Cancer Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Eye Cancer Treatment Product Solution and Service
Table 23. Date of Enter into Eye Cancer Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Eye Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Eye Cancer Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Eye Cancer Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Eye Cancer Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Eye Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Eye Cancer Treatment Revenue Share by Application (2017-2022)
Table 31. Global Eye Cancer Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Eye Cancer Treatment Revenue Share by Application (2023-2028)
Table 33. North America Eye Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Eye Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Eye Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Eye Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Eye Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Eye Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Eye Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Eye Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Eye Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Eye Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Eye Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Eye Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Eye Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Eye Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Eye Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Eye Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Eye Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Eye Cancer Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Eye Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Eye Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Eye Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Eye Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Eye Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Eye Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Eye Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Eye Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Eye Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Eye Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Eye Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Eye Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 63. Novartis AG Company Details
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Eye Cancer Treatment Product
Table 66. Novartis AG Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 67. Novartis AG Recent Developments
Table 68. Spectrum Pharmaceuticals,Inc Company Details
Table 69. Spectrum Pharmaceuticals,Inc Business Overview
Table 70. Spectrum Pharmaceuticals,Inc Eye Cancer Treatment Product
Table 71. Spectrum Pharmaceuticals,Inc Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 72. Spectrum Pharmaceuticals,Inc Recent Developments
Table 73. GlaxoSmithKline plc Company Details
Table 74. GlaxoSmithKline plc Business Overview
Table 75. GlaxoSmithKline plc Eye Cancer Treatment Product
Table 76. GlaxoSmithKline plc Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 77. GlaxoSmithKline plc Recent Developments
Table 78. Bayer AG Company Details
Table 79. Bayer AG Business Overview
Table 80. Bayer AG Eye Cancer Treatment Product
Table 81. Bayer AG Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 82. Bayer AG Recent Developments
Table 83. Amgen ,Inc Company Details
Table 84. Amgen ,Inc Business Overview
Table 85. Amgen ,Inc Eye Cancer Treatment Product
Table 86. Amgen ,Inc Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 87. Amgen ,Inc Recent Developments
Table 88. Takeda Pharmaceuticals Company Limited Company Details
Table 89. Takeda Pharmaceuticals Company Limited Business Overview
Table 90. Takeda Pharmaceuticals Company Limited Eye Cancer Treatment Product
Table 91. Takeda Pharmaceuticals Company Limited Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 92. Takeda Pharmaceuticals Company Limited Recent Developments
Table 93. Eli Lilly and Company Company Details
Table 94. Eli Lilly and Company Business Overview
Table 95. Eli Lilly and Company Eye Cancer Treatment Product
Table 96. Eli Lilly and Company Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 97. Eli Lilly and Company Recent Developments
Table 98. AstraZeneca Company Details
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Eye Cancer Treatment Product
Table 101. AstraZeneca Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 102. AstraZeneca Recent Developments
Table 103. F.Hoffmann-La Roche Ltd Company Details
Table 104. F.Hoffmann-La Roche Ltd Business Overview
Table 105. F.Hoffmann-La Roche Ltd Eye Cancer Treatment Product
Table 106. F.Hoffmann-La Roche Ltd Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 107. F.Hoffmann-La Roche Ltd Recent Developments
Table 108. Janssen Global Services ,LLC Company Details
Table 109. Janssen Global Services ,LLC Business Overview
Table 110. Janssen Global Services ,LLC Eye Cancer Treatment Product
Table 111. Janssen Global Services ,LLC Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 112. Janssen Global Services ,LLC Recent Developments
Table 113. Sanofi Company Details
Table 114. Sanofi Business Overview
Table 115. Sanofi Eye Cancer Treatment Product
Table 116. Sanofi Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 117. Sanofi Recent Developments
Table 118. Abbvie ,Inc Company Details
Table 119. Abbvie ,Inc Business Overview
Table 120. Abbvie ,Inc Eye Cancer Treatment Product
Table 121. Abbvie ,Inc Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 122. Abbvie ,Inc Recent Developments
Table 123. Pfizer ,Inc Company Details
Table 124. Pfizer ,Inc Business Overview
Table 125. Pfizer ,Inc Eye Cancer Treatment Product
Table 126. Pfizer ,Inc Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 127. Pfizer ,Inc Recent Developments
Table 128. Merck & Co,Inc Company Details
Table 129. Merck & Co,Inc Business Overview
Table 130. Merck & Co,Inc Eye Cancer Treatment Product
Table 131. Merck & Co,Inc Revenue in Eye Cancer Treatment Business (2017-2022) & (US$ Million)
Table 132. Merck & Co,Inc Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Eye Cancer Treatment Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. Intravenous Features
Figure 4. Tropical Features
Figure 5. Others Features
Figure 6. Global Eye Cancer Treatment Market Share by Application: 2021 VS 2028
Figure 7. Hospital Case Studies
Figure 8. Clinics Case Studies
Figure 9. Cancer Centers Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Eye Cancer Treatment Report Years Considered
Figure 14. Global Eye Cancer Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Eye Cancer Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Eye Cancer Treatment Market Share by Region: 2021 VS 2028
Figure 17. Global Eye Cancer Treatment Market Share by Players in 2021
Figure 18. Global Top Eye Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Cancer Treatment as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Eye Cancer Treatment Revenue in 2021
Figure 20. North America Eye Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Eye Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 22. North America Eye Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 23. North America Eye Cancer Treatment Market Size Share by Country (2017-2028)
Figure 24. United States Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Eye Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Eye Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 28. Europe Eye Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 29. Europe Eye Cancer Treatment Market Size Share by Country (2017-2028)
Figure 30. Germany Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Eye Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Eye Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Eye Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Eye Cancer Treatment Market Size Share by Region (2017-2028)
Figure 40. China Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Eye Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Eye Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Eye Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Eye Cancer Treatment Market Size Share by Country (2017-2028)
Figure 50. Mexico Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Eye Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Eye Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Eye Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Eye Cancer Treatment Market Size Share by Country (2017-2028)
Figure 56. Turkey Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Eye Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Novartis AG Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 60. Spectrum Pharmaceuticals,Inc Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 61. GlaxoSmithKline plc Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 62. Bayer AG Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 63. Amgen ,Inc Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 64. Takeda Pharmaceuticals Company Limited Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 65. Eli Lilly and Company Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 66. AstraZeneca Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 67. F.Hoffmann-La Roche Ltd Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 68. Janssen Global Services ,LLC Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 69. Sanofi Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 70. Abbvie ,Inc Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 71. Pfizer ,Inc Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 72. Merck & Co,Inc Revenue Growth Rate in Eye Cancer Treatment Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---